What is she best known for?
The fields of study she is best known for:
- Immune system
- Antigen
- Virus
Rhea N. Coler mainly focuses on Virology, Immunology, Antigen, Adjuvant and Immune system.
In Virology, Rhea N. Coler works on issues like Leishmaniasis Vaccines, which are connected to Immunogenicity.
Her Antigen research integrates issues from Vaccination, Cytotoxic T cell, Recombinant DNA and Mycobacterium tuberculosis.
In her research, Chlamydia is intimately related to Antibody, which falls under the overarching field of Vaccination.
Her Adjuvant study integrates concerns from other disciplines, such as Lipid A and TLR4.
She is interested in Immunity, which is a branch of Immune system.
Her most cited work include:
- New horizons in adjuvants for vaccine development (557 citations)
- Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. (268 citations)
- Taking toll: lipid A mimetics as adjuvants and immunomodulators. (248 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Immunology, Adjuvant, Virology, Antigen and Immune system.
Her Immunology study frequently links to related topics such as Tuberculosis vaccines.
Her Adjuvant study combines topics in areas such as Monophosphoryl Lipid A, Lipid A, Fusion protein and Immunogenicity.
Her Virology research incorporates themes from Leishmania major, Leishmaniasis Vaccines, Immunization and Mycobacterium tuberculosis.
Her research in Antigen focuses on subjects like T cell, which are connected to CD8.
Her Immune system research integrates issues from Tumor necrosis factor alpha, Cytokine and Pharmacology.
She most often published in these fields:
- Immunology (60.00%)
- Adjuvant (55.24%)
- Virology (52.38%)
What were the highlights of her more recent work (between 2014-2020)?
- Immunology (60.00%)
- Adjuvant (55.24%)
- Virology (52.38%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Immunology, Adjuvant, Virology, Antigen and Vaccination.
Her Immunology study is mostly concerned with Immune system, Immunogenicity, Visceral leishmaniasis, CD8 and T cell.
Her Adjuvant study combines topics from a wide range of disciplines, such as Cytokine, Gastroenterology, Cellular immunity, Cytotoxic T cell and Intramuscular injection.
Her work carried out in the field of Virology brings together such families of science as Leishmaniasis Vaccines, Immunity and Mycobacterium tuberculosis.
Her research integrates issues of Influenza A virus subtype H5N1, Antibody and Potency in her study of Antigen.
The Vaccination study which covers Tuberculosis vaccines that intersects with Clinical trial and Systems biology.
Between 2014 and 2020, her most popular works were:
- Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens. (124 citations)
- From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE. (89 citations)
- Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial (62 citations)
In her most recent research, the most cited papers focused on:
- Immune system
- Antigen
- Virus
Rhea N. Coler mainly investigates Adjuvant, Immunology, Virology, Vaccination and Antigen.
Her work deals with themes such as Visceral leishmaniasis and Immune system, which intersect with Adjuvant.
Her studies in Immune system integrate themes in fields like Chlamydia, Antibody and Antibody titer.
She combines subjects such as Tuberculosis vaccines and Mycobacterium tuberculosis with her study of Immunology.
In general Antigen study, her work on Hemagglutinin often relates to the realm of H5N1 vaccine, thereby connecting several areas of interest.
Her Immunogenicity research includes elements of Immunoglobulin E and Tolerability.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
